| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/18/2009 | CN101366745A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366744A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366743A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366742A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366741A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366740A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366731A Propolis flavone, preparation method and uses in treating diabetes |
| 02/18/2009 | CN101366712A Method for preparing fat-soluble vitamin for injection |
| 02/18/2009 | CN101366707A Application of triacontanol in preparing medicament for treating hyperlipemia, medicament formulation and preparation method thereof |
| 02/18/2009 | CN101366698A Biogastrone acid prosome liposome with long circulation function and preparation method thereof |
| 02/18/2009 | CN101366694A Tribiofosfor injection and preparation method thereof |
| 02/18/2009 | CN101366692A Stable Exenatide formulation |
| 02/18/2009 | CN101366529A Xanthophyll nourishing beverage, xanthophyll milk |
| 02/18/2009 | CN101366528A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366527A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366526A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366514A Folium nelumbinis and whitethorn weight losing tea |
| 02/18/2009 | CN100462361C Formononetin-3'-sodium sulfonate, prunetin-3'-sodium sulfonate and their preparation process and medicinal use |
| 02/18/2009 | CN100462359C 5-sulfanyl-4H-1,2,4-triazole derivatives and their use as a medicament |
| 02/18/2009 | CN100462351C Amino acids with affinity for the alpha-2-delta-protein |
| 02/18/2009 | CN100462085C Medicament or health food tablet for regulating blood sugar, blood pressure and blood lipid and their making method |
| 02/18/2009 | CN100462073C Compositions useful for the treatment of pathologies responding to the activation of PPAR-gamma receptor |
| 02/18/2009 | CN100462067C Preparation method of sodium iron chlorophyllin-ethyl cellulose microcapsule |
| 02/17/2009 | US7491796 Retro-inversion peptides that target GIT receptors and related methods |
| 02/17/2009 | US7491747 4-(Arylthio)- or (4-heteroarylthio)butyric acid derivatives that may be used in the treatment of dyslipidaemia, atherosclerosis and diabetes |
| 02/17/2009 | US7491740 Isoxazoline compounds having MIF antagonist activity |
| 02/17/2009 | US7491733 Bicyclic guanidine derivatives and therapeutic uses thereof |
| 02/17/2009 | US7491730 Compositions useful as inhibitors of GSK-3 |
| 02/17/2009 | US7491716 Glycogen synthase kinase-3 inhibitors such as [1-(4-Imidazo[1,2-a]pyridin-3-yl-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)-6,7-dihydro-6H-[1,4]diazepino[6,7,1-hi]indol-6-yl]-[morpholin-4-yl]methylenecyanamide, used for treating diabetes, Alzheimer's disease and for stimulating bone deposition in mammals |
| 02/17/2009 | US7491703 Tetrapeptide regulating blood glucose level in diabetes mellitus |
| 02/17/2009 | US7491677 Composite sample on support; concentration gradients |
| 02/17/2009 | US7491410 Food grade transglutaminase inhibitor and uses thereof |
| 02/17/2009 | US7491401 Lawsonia intracellularis vaccine |
| 02/17/2009 | US7491392 An isolated IL-1 beta binding molecule comprising a heavy chain variable domain; treatment of an IL-1 mediated disease or disorder, e.g. osteoarthritis, osteroporosis and other inflammatory arthritis |
| 02/17/2009 | US7491381 screening of therapeutic agents for obesity or emaciation is performed utilizing the nature of long chanin fatty acid elonage gene or protein. |
| 02/17/2009 | CA2428315C Indole and dihydroindole derivatives |
| 02/17/2009 | CA2257010C Methods and compositions for the treatment and prevention of tumors, tumor-related disorders and cachexia |
| 02/12/2009 | WO2009021113A1 Methods for enhancing glutahione peroxidase activity |
| 02/12/2009 | WO2009020802A2 Use of an fgf-21 compound and a glp-1 compound for the treatment of obesity |
| 02/12/2009 | WO2009020140A1 Adamantylurea derivative |
| 02/12/2009 | WO2009020137A1 Aminopyrazole amide derivative |
| 02/12/2009 | WO2009020119A1 Pharmaceutical containing hif-1 alpha and hif-2 alpha expression inhibitor |
| 02/12/2009 | WO2009019835A1 Crude drug extract-blended liquid medicine |
| 02/12/2009 | WO2009019815A1 Novel γ-secretase inhibitor |
| 02/12/2009 | WO2009019566A1 Phenoxy-pyrrolidine derivative and its use and compositions |
| 02/12/2009 | WO2009019202A1 N-(2-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases |
| 02/12/2009 | WO2009019199A1 Crystalline teglicar |
| 02/12/2009 | WO2009019149A1 Pyridinecarboxamide and benzamide derivatives as taar1 ligands |
| 02/12/2009 | WO2009018780A1 Andrographolide derivatives and use thereof in manufacture of medicaments |
| 02/12/2009 | WO2008127349A3 Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid level |
| 02/12/2009 | WO2008033460A3 Treating pain, diabetes, and lipid metabolism disorders |
| 02/12/2009 | US20090044299 Artichoke hybrid named 'PS-H2015' |
| 02/12/2009 | US20090043129 Potent and selective ligands of cannabinoid receptors |
| 02/12/2009 | US20090042967 androgen receptor modulators; specific pyrrolidinone-functional benzonitrile compounds such as 2-Chloro-4-[4-hydroxy-5-methyl-2-oxopyrrolidin-1-yl]benzonitrile or 2-Chloro-4-[5-ethyl-3,3-difluoro-4-hydroxy-2-oxopyrrolidin-1-yl]benzonitrile |
| 02/12/2009 | US20090042953 IMIDAZO [2,1,-b]-1,3,4-THIADIAZOLE SULFONAMIDES |
| 02/12/2009 | US20090042929 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors |
| 02/12/2009 | US20090042926 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment |
| 02/12/2009 | US20090042919 Method for modulating gpr119 g protein-coupled receptor and selected compounds |
| 02/12/2009 | US20090042911 Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-YL](3R,5S)-3, 5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4 |
| 02/12/2009 | US20090042903 For treatment and/or prevention of diseases which are associated with the modulation of H3 receptors; obesity; N-[2-(4-ethyl-piperazin-1-yl)-pyridin-4-yl]-C-phenyl-methanesulfonamide; C-(4-chloro-phenyl)-N-[2-(4-ethyl-piperazin-1-yl)-pyridin-4-yl]-methanesulfonamide |
| 02/12/2009 | US20090042897 Chemical Compounds |
| 02/12/2009 | US20090042890 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 02/12/2009 | US20090042884 kinase inhibitor; immunotherapy; viricides; function or behavior associated with PI3 kinase such as cancer, immune, cardiovascular, nervous system, metabolism/endocrine and neurological diseases, viral infection, inflammation; 6-(indol-4-yl)-4-(morpholin-4-yl)-2-[(2-(pyridin-2-yl)ethylamino]pyrimidine |
| 02/12/2009 | US20090042877 such as ethyl 6-oxo-7-phenyl-3-(pyridin-3-ylamino)-6,7-dihydrothieno [2,3-b]pyridine-2-carboxylate, potent and selective inhibitors of p38 MAP kinase and are of use in the prophylaxis and treatment of immune or inflammatory disorders |
| 02/12/2009 | US20090042873 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use |
| 02/12/2009 | US20090042872 Rhodanine Derivatives, a Process for the Preparation Thereof and Pharmaceutical Composition Containing the Same |
| 02/12/2009 | US20090042866 Tetrahydrocarbazoles as Active Agents for Inhibiting VEGF Production by Translational Control |
| 02/12/2009 | US20090042851 Sulfonamide derivatives, preparation thereof and use thereof as antagonists of orexin 2 receptors |
| 02/12/2009 | US20090042842 Analogues of cilostazol |
| 02/12/2009 | US20090042813 Hoodia extract oil compositions comprising medium chain triglycerides |
| 02/12/2009 | US20090042807 By reducing macrophage NO production through administration of one or more enzyme inhibitors, selected from tripeptides, tetrapeptides and pentapeptides; inhibition of neucrosis factor kappa Beta mediated inflammatory cytokine release |
| 02/12/2009 | US20090042791 Integrin binding motif containing peptides and methods of treating skeletal diseases |
| 02/12/2009 | US20090042790 Transmucosal delivery of peptide derivatives |
| 02/12/2009 | US20090042779 Purified Extract of an Alpha-Amylase Inhibitor From Phytoemagglutinin-Essentially Free Beans, Process for Its Extraction and Compositions Containing It |
| 02/12/2009 | US20090042199 Nucleotide sequences coding lymphocyte adhesion protein for use in treatment of autoimmunity, inflammation and infection |
| 02/12/2009 | US20090041873 Anti-diabetic extract isolated from rauvolfia vomitoria and citrus aurantium, and methods of using same |
| 02/12/2009 | US20090041854 Parathyroid and thymus transplantation in digeorge syndrome subjects |
| 02/12/2009 | US20090041851 Composition for the delivery of live cells and methods of use thereof |
| 02/12/2009 | US20090041843 Pharmaceutical preparation having excellent photostability |
| 02/12/2009 | US20090041768 Modified Fc molecules |
| 02/12/2009 | US20090041735 CD34 Stem cell-related methods and compositions |
| 02/12/2009 | US20090041731 Treatment for Diabetes |
| 02/12/2009 | CA2702711A1 Liquid preparation containing herb and/or animal-origin extract |
| 02/12/2009 | CA2695877A1 Novel .gamma.-secretase inhibitor |
| 02/12/2009 | CA2695664A1 Phenoxy-pyrrolidine derivative and its use and compositions |
| 02/12/2009 | CA2695621A1 Pyridine carboxamide orexin receptor antagonists |
| 02/12/2009 | CA2695437A1 Aminopyrazole amide derivative |
| 02/12/2009 | CA2695405A1 N-(2-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases |
| 02/12/2009 | CA2695331A1 Pyridinecarboxamide and benzamide derivatives as taar1 ligands |
| 02/12/2009 | CA2693504A1 Treatment for obesity |
| 02/11/2009 | EP2022505A2 GLP-1, exendin-4, peptide analogs and uses thereof |
| 02/11/2009 | EP2022502A1 Lactobacillus rhamnosus and weight control |
| 02/11/2009 | EP2022495A1 Composition for preventing the occurrence of cardiovascular event in multiple risk patient |
| 02/11/2009 | EP2021467A1 Chimeric pcsk9 proteins, cells comprising same, and assays using same |
| 02/11/2009 | EP2021368A1 Derivatized insulin oligomers |
| 02/11/2009 | EP2021365A2 Use of ghrelin splice variant for treating high cholesterol levels or high plasma glucose levels and releated diseases |
| 02/11/2009 | EP2021339A1 Rosiglitazone hydrochloride hemihydrate |
| 02/11/2009 | EP2021337A2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 02/11/2009 | EP2021336A2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 02/11/2009 | EP2021321A2 2-methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin d3 and uses thereof |